Clinical trials query results
From Health Canada
- Medical condition:
- FRAGILE X SYNDROME
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- PSILOCYBIN
- Protocol title:
- AN OPEN-LABEL INVESTIGATION OF THE EFFECTS OF SUB-PERCEPTUAL REPEAT DOSING OF PSILOCYBIN ON THE BEHAVIOURAL AND COGNITIVE SYMPTOMS OF FRAGILE X SYNDROME IN ADULT PATIENTS
- Sponsor name:
- NOVA MENTIS LIFE SCIENCE CORP
- Date of no objection letter:
- 2022-12-21
- Control number:
- 269922
- Trial status:
- ONGOING
- Date study started:
- 2023-04-24